Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 1,189,390 |
|
|||||
| News | (1) | ||||||
| Day High | 3.63 | Low High |
|||||
| Day Low | 3.42 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Mersana Therapeutics Inc | MRSN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.10 | 2.98% | 3.46 | 18:39:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.52 | 3.42 | 3.63 | 3.46 | 3.36 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,150 | 1,189,390 | US$ 3.51 | US$ 4,171,101 | - | 0.8014 - 9.62 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:36:39 | 1 | US$ 3.58 | USD |
Mersana Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 419.71M | 121.30M | - | 36.86M | -171.67M | -1.42 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Mersana Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRSN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.84 | 3.63 | 2.76 | 3.24 | 1,397,692 | 0.62 | 21.83% |
| 1 Month | 4.23 | 4.44 | 2.745 | 3.40 | 1,655,335 | -0.77 | -18.20% |
| 3 Months | 4.24 | 6.2801 | 2.745 | 4.44 | 2,268,076 | -0.78 | -18.40% |
| 6 Months | 1.26 | 6.2801 | 1.15 | 3.44 | 2,054,421 | 2.20 | 174.60% |
| 1 Year | 5.21 | 9.62 | 0.8014 | 2.75 | 3,536,452 | -1.75 | -33.59% |
| 3 Years | 15.99 | 16.495 | 0.8014 | 4.19 | 1,959,472 | -12.53 | -78.36% |
| 5 Years | 4.83 | 29.09 | 0.8014 | 6.75 | 1,495,894 | -1.37 | -28.36% |
Mersana Therapeutics Description
| Mersana Therapeutics Inc is a clinical stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefit to patients. Mersana's product candidate, XMT-1536, is in a Phase 1 clinical trial in patients with tumors expressing NaPi2b, including ovarian cancer, NSCLC, and other cancers. In addition, multiple partners are using Mersana's platform to advance their ADC pipelines. |
